The ACT Annual Meeting offers an opportunity for toxicologists preparing for the challenges and decisions that will affect public health and safety in years to come. The meeting will include a wide range of scientific programs, welcome reception and dinner, the popular poster session reception, awards ceremony, and luncheon, distinguished speakers, and networking events.
The Toxicology Unit at the Laboratory Testing Division is a full-service provider of preclinical and clinical stage safety assessments for biologic and small molecule drugs. Whether you require a four-week rodent study for an IND, or a two-year carcinogenicity study for an NDA, the Toxicology Unit has the scientific expertise, technical experience and regulatory understanding to handle your project to the highest international quality standards, no matter the scope or scale.
Come to the WuXi AppTec Laboratory Testing Division Booth #311 to learn more from the Toxicology Unit’s scientific experts on how they can help you move your drug through the developmental pipeline and save you time and costs on your IND submission. The scientific experts can also offer you more detailed information about the General Toxicology, Safety Pharmacology, Genetic Toxicology, Developmental and Reproductive Toxicology (DART), and Ocular Toxicology Services offered by WuXi AppTec Laboratory Testing Division.
Sue McPherson, Executive Director, Toxicology Services, will be presenting, Drug Development: From IND Enabling Studies to Document Preparation and Submission; on Wednesday, November 7th at 7:00am - 7:55am. To learn more about strategy and guidance for your preclinical program you will want to attend this exhibitor hosted session.
To schedule a meeting WuXi AppTec Laboratory Testing Division contact us.